InvestorsObserver
×
News Home

Is Travere Therapeutics Inc (TVTX) a Leader in the Healthcare Sector?

Monday, May 23, 2022 04:01 PM | InvestorsObserver Analysts

Mentioned in this article

Is Travere Therapeutics Inc (TVTX) a Leader in the Healthcare Sector?

A rating of 92 puts Travere Therapeutics Inc (TVTX) near the top of the Healthcare sector according to InvestorsObserver. Travere Therapeutics Inc's score of 92 means that it ranks higher than 92% of stocks in the sector. In addition, its overall score of 81 ranks it higher than 81% of all stocks.

Overall Score - 81
TVTX has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on TVTX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 81 means the stock is more attractive than 81 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Travere Therapeutics Inc Stock Today?

Travere Therapeutics Inc (TVTX) stock is lower by -4.59% while the S&P 500 is up 1.86% as of 4:00 PM on Monday, May 23. TVTX is down -$1.11 from the previous closing price of $24.18 on volume of 361,907 shares. Over the past year the S&P 500 has fallen -5.32% while TVTX is up 28.45%. TVTX lost -$3.27 per share the over the last 12 months. Click Here to get the full Stock Report for Travere Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App